In preparation for the 2024 Mid-Term Review, the Commission will conduct in 2023 a comprehensive stock-taking of progress made in implementing all international drug policy commitments to address the challenges identified in the 2019 Ministerial Declaration. The thematic discussions will consist of two intersessional meetings - the first one will take place from 23 to 25 October 2023 and the second one from 4 to 6 December 2023. Each half-day will be devoted to one specific challenge, as per the below:
📌 On 25 October at 13:00, Boardroom D of the Vienna International Centre and online, the Chair of the CND will provide a briefing to all interested stakeholders on the High Level Segment of the 2024 Mid-term Review.
The thematic discussions will be held in English only. The morning meeting will be held from 10:00 a.m. to 1:00 p.m. (Vienna time), and the afternoon meetings from 3:00 p.m. to 6:00 p.m.
The thematic discussions will be organized in two parts for each challenge:
For further details, please consult the organizational arrangements agreed by the Commission.